• About us
• Contact

Advertisement

Organisation › Details

OrbiMed (Group)

OrbiMed is a leading healthcare investment firm, with approximately $19 billion in assets under management. OrbiMed invests globally across the healthcare industry through a range of private equity funds, public equity funds, and royalty/credit funds. OrbiMed’s team of over 100 professionals is based in New York City, San Francisco, Shanghai, Hong Kong, Mumbai, Herzliya and other key global markets. *

 

	Start	1989-01-01 established
	Industry	private equity
	Industry 2	LIFE SCIENCES
	Region	New York, NY
	Country	United States (USA)
	Street	601 Lexington Avenue 54th Floor
	City	10022 New York, NY
	Tel	+1-212-739-6400
		Address record changed: 2021-12-06
Basic data	Employees	D: 101 to 500 (2023-10-24)
	Currency	USD
	Annual sales	17,000,000,000 (assets under management (2023) 2023-10-24)
		* Document for »About Section«: Nerre Therapeutics Ltd.. (7/7/21). "Press Release: Nerre Therapeutics Raises £20 Million in a Series B2 Financing Round". Stevenage.
		Record changed: 2025-09-08

Advertisement

More documents for OrbiMed (Group)

• [1] Windward Bio AG. (5/4/26). "Press Release: Windward Bio Announces $165M Crossover Financing to Advance Pipeline of Long-Acting Immunology Therapies With Best-in-Disease Potential". Basel....
• [2] Alentis Therapeutics AG. (11/12/24). "Press Release: Alentis Therapeutics Raises $181.4 Million in an Oversubscribed Series D Financing to Advance the Clinical Development of Anti-Claudin-1 ADCs in Solid Tumors". Basel....
• [3] Gibbs, Matthew [CipherBio = SVB]. (9/30/20). "News: Blog – Biotech Funding – The Tale of Three Regions. 2020 YTD in Numbers – the US, Europe and Asia"....
• [4] Lysogene S.A.. (3/12/20). "Press Release: Lysogene Completes €7.7 Million Capital Increase in a Placement Led by Leading Healthcare Investor OrbiMed and Lysogene Shareholder and Partner Sarepta [Not for US, CA, AU or JP]". Paris....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to [email protected] and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Advertisement

» top

» Imprint  |  » Data Privacy  |  » Contact  |  The use of this website requires to accept the » Disclaimer!   |  A project of [iito] Business Intelligence © 2002-2026. Made in Germany.